![](/img/cover-not-exists.png)
Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer
Lenos, K., Grawenda, A. M., Lodder, K., Kuijjer, M. L., Teunisse, A. F. A. S., Repapi, E., Grochola, L. F., Bartel, F., Hogendoorn, P. C. W., Wuerl, P., Taubert, H., Cleton-Jansen, A.-M., Bond, G. L.,Volume:
72
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.can-12-0215
Date:
August, 2012
File:
PDF, 903 KB
english, 2012